CLICK HERE TO LEARN MORE OR REGISTER
Live Webinar + On-Demand Course Access
AI-Driven Drug Discovery: Protecting Patent Rights and Avoiding IP Pitfalls in the Race for Innovation
Wednesday, October 7, 2026, from 12:00 PM to 1:00 PM (ET)
The use of artificial intelligence in drug discovery is creating complex intellectual property issues for attorneys advising pharmaceutical companies, biotechnology companies, technology developers, and other stakeholders. AI-assisted inventions raise important questions concerning patent eligibility, inventorship, ownership, and the scope and strength of patent protection, particularly as AI tools become increasingly involved in the development of potentially patentable innovations.
In this CLE webinar, speakers will draw on their extensive experience in software and AI patent law to examine key legal issues involved in protecting AI-driven innovations. Attendees will gain practical guidance on evaluating patentable subject matter, addressing inventorship and ownership issues, and developing patent strategies that account for the use of AI in the inventive process. The program will also address legal risks that may arise when drafting and prosecuting patents for AI-related technologies, including considerations under Alice and evolving U.S. patent law.
What You Will Learn in this Webinar
- Identify key patent eligibility, inventorship, and ownership issues arising from AI-assisted drug discovery and development.
- Evaluate patent protection strategies for AI-related inventions while addressing risks under Alice and applicable U.S. patent law.
- Advise clients on patent drafting and prosecution considerations to strengthen protection for AI-driven technologies and avoid common IP pitfalls.